2011
DOI: 10.18553/jmcp.2011.17.6.430
|View full text |Cite
|
Sign up to set email alerts
|

Attitudes of Florida Pharmacists Toward Implementing a State Prescription Drug Monitoring Program for Controlled Substances

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(13 citation statements)
references
References 12 publications
0
13
0
Order By: Relevance
“…[99][100][101] While studies of pharmacists are more limited, pharmacists' attitudes toward PDMPs have been positive, with their primary use of the programs being to help reduce doctor shopping. 102 One of the most straightforward uses of PDMPs is altering this aberrant patient behavior by providing a coordinated and convenient source of controlled substance use information to prescribers, pharmacists, and law enforcement. One study showed that PDMP implementation reduced the time necessary to conduct investiga-tions into possible doctor shopping from 156 to 16 days.…”
Section: Prescription Drug Monitoring Programsmentioning
confidence: 99%
“…[99][100][101] While studies of pharmacists are more limited, pharmacists' attitudes toward PDMPs have been positive, with their primary use of the programs being to help reduce doctor shopping. 102 One of the most straightforward uses of PDMPs is altering this aberrant patient behavior by providing a coordinated and convenient source of controlled substance use information to prescribers, pharmacists, and law enforcement. One study showed that PDMP implementation reduced the time necessary to conduct investiga-tions into possible doctor shopping from 156 to 16 days.…”
Section: Prescription Drug Monitoring Programsmentioning
confidence: 99%
“…Checking the PMP was rated as of higher importance by APRNs and physicians than pharmacists. Although pharmacists reported positive intention to use a PMP in previous studies (Fass & Hardigan, 2011;Fleming et al, 2014;Gavaza, Fleming, & Barner, 2014), the findings suggested the intention may be more conditional compared with prescribers. Possible reasons for the relatively lower values for PMP use may include lower self-efficacy among pharmacists to address prescription misuse, limited access to patient information, and technical barriers like PMP complexity and usability (Cochran, Field, Lawson, & Erickson, 2013;Hartung et al, 2018;Norwood & Wright, 2016).…”
Section: Influence Of Respondent Variablesmentioning
confidence: 68%
“…Three years later, 21 states do so. ( 8 , 9 ). However, some states do not have prescription monitoring programs in place or they are not operational ( 10 ) and may never find the funding to do so.…”
Section: Discussionmentioning
confidence: 99%